Active Brain & Nervous System Genetics & Molecular Biology

Computational Modelling and Inference of Neurodegenerative Disease Propagation

In plain English

AI plain-English summary

A new computational framework will track how neurodegenerative diseases like Alzheimer’s spread through the brain, accounting for the uncertainties that have made previous models unreliable. Current models linking brain scans to disease progression are crude and largely qualitative. They fail to account for patient-to-patient differences or errors in mapping the brain’s wiring diagram. This project tackles both problems head-on. First, it uses machine learning to identify fine-grained disease subtypes from multi-modal biomarker data, untangling the heterogeneity that has confounded earlier attempts. Second, it introduces a probabilistic approach to brain connectomics—quantifying the likelihood of false connections—so that propagation models can work despite inevitable mapping errors. If successful, the framework will provide the first truly quantitative evaluation of how pathology spreads across the brain. This could transform how clinicians interpret imaging data, enabling earlier and more accurate diagnosis, and helping to stratify patients for clinical trials. The work is fundamental science: it builds the mathematical and computational tools needed to test mechanistic hypotheses about neurodegeneration. Deeper understanding of propagation mechanisms could eventually guide the design of therapies that slow or halt disease spread.

View original technical description
This project uses computational modelling, machine learning, and big-data analysis to address key unknowns on the biology of neurodegenerative disease: when and where it starts; how it spreads over the brain (“propagates”); how it varies among diseases, subtypes, and individuals; how risk factors influence mechanisms. Current models linking imaging and other clinical data to propagation mechanisms are crude, and evaluation remains largely qualitative. The project introduces a powerful Bayesian inference framework, accounting for uncertainties throughout the data-processing pipeline, to enable robust evidence quantification of new and detailed computational models of disease propagation. The approach demands a rethink of contributing technologies. First, we unravel patient heterogeneity, which confounds propagation-model evaluation, through a new generation of data-driven disease progression models that identify fine-grained disease subtypes characterised by temporal trajectory of multi-modal biomarkers. Second, propagation models use brain connectome estimates and are confounded by high connection-error rates. We establish a new probabilistic connectomics paradigm that quantifies likelihoods of false positive and negative connections enabling models to mitigate their inevitable presence. We use the framework to provide the first truly quantitative evaluation of propagation models against state-of-the-art data sets leading to fundamental new insights on the mechanisms of pathology propagation in neurodegenerative diseases.

View the original record at the funder ↗

Researchers

Daniel Alexander (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Computational models of neurodegenerative disease progression
Bayesian inference of neurodegenerative spreading models
Multiscale modelling of the microstructural evolution of nervous tissues through high-performance computing
Computational modelling for understanding mechanisms of Alzheimer's disease progression
Discovering early biomarkers of Alzheimer's disease using genetic and physics-informed networks

Original classification

Investigator Award in Science

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.